Research Article
Volume 1 Issue 2 - 2017
Association between Sleep Quality and Glucose Control in Filipino Adults with Type 2 Diabetes Mellitus
Abigail C Zaraspe MD1, Virginia S Delos Reyes MD2* and Cecilia A Jimeno MD3
1Department of Pulmonary, Critical Care and Sleep Medicine, Lung Center of the Philippines, Quezon City Philippines
2Department of Pulmonary, Critical Care and Sleep Medicine, Lung Center of the Philippines, Quezon City Philippines
3Section of Endocrinology and Metabolism and Department of Pharmacology, University of the Philippines, Quezon City Philippines
*Corresponding Author: Virginia S Delos Reyes MD, Department of Pulmonary, Critical Care and Sleep Medicine, Lung Center of the Philippines, Quezon City Philippines.
Received: November 03, 2017; Published: November 20, 2017
Abstract
Introduction: Studies show that patients with short or poor sleep quality affects glucoregulation and quality of life negatively. A review of local literature has not revealed any studies on the topic of the association between sleep quality and glucose control. The general objective of this study is to determine the association between sleep quality and glucose control among Filipino adults with T2DM.
Methods: Cross-sectional analytic study involving adult individuals with Type 2 diabetes mellitus seen consecutively at various outpatient clinics of the Lung Center of the Philippines and National Kidney and Transplant Institutes from September 2015 to May 2016.
Participants were 241 adults with type 2 diabetes (T2DM). Sleep quality was measured using the Pittsburg Sleep Quality Index Questionnaire. HbA1c within one month of the interview was used to assess glucose control with self-reported daytime sleepiness. Berlin Questionnaire and Epworth Sleepiness Scale were used to screen for obstructive sleep apnea and excessive daytime sleepiness respectively.
Result: Poor sleep quality was noted in 55% of Filipino diabetics in the study population. And among those with poor sleep, 70.45% have poor glycemic control. We found that sleep quality is directly although weakly correlated with glucose control.
Patients with poor glucose control were more likely to have poor sleep quality (OR 5.5012, 95% CI 3.0881 to 9.7997, p = 0.0000.
HbA1c, asthma/COPD, and lack of bedroom companion are predictors of poor sleep quality among adult diabetic Filipinos based on PSQI scoring.
Among the study population, 33% are high risk for sleep disordered breathing using the Berlin questionnaire and only 26% have excessive daytime sleepiness using ESS.
Conclusion: The prevalence of poor sleep among diabetic Filipinos is high at 55%. Poor sleep quality is directly correlated with poor glucose control. Factors that worsen sleep quality among T2DM are elevated hbA1c, obstructive airway disease and sleeping alone in a bedroom.
Keywords: Glucose control; Type 2 Diabetes Mellitus; Sleep Quality
Abbreviations: COPD: Chronic Obstructive Pulmonary Disease; ESS: Epworth Sleepiness Scale; HbA1C: Hemoglobin A1c; OSA: Obstructive Sleep Apnea; PEEP: Positive End Expiratory Pressure; PSQI:- Pittsburg Sleep Quality Index; SWS: Slow wave sleep; T2DM: type 2 Diabetes Mellitus
Introduction
Type 2 diabetes is one of the most common non-communicable diseases. In 2014, there were 3.2 million cases of diabetes in the Philippines with 5.9% prevalence. [1] Diabetes related complications including cardiovascular disease, kidney disease, neuropathy, loss of vision and sexual dysfunction, significantly contribute to morbidity and mortality.
Aside from medications, lifestyle changes, weight loss management and increased physical activity are designed to prevent and manage diabetes. Despite these, incidence of diabetes is still on the rise and glycemic control is often difficult to achieve. [2-4] New strategies need to be developed to help with glucose control.
Studies have shown that short or disturbed sleep affects glucoregulation negatively (i.e. glucose intolerance and insulin resistance) [5] Diabetic patients also have poor sleep quality that affects their quality of life. [3,6] Sleep disorders were noted to have a negative impact on disease control on Chinese, Japanese, Korean and American population. [6-11] Filipinos have a higher rate of diabetes compared to other Asians. [12] A review of local literature has not revealed any studies on the topic of the association between sleep quality and glucose control.
The general objective of this study is to determine the association between sleep quality and glucose control among Filipino adults with T2DM. This study will also aim to determine the prevalence of having poor sleep quality among Filipino T2DM patients, their clinical profile; determine the correlation between sleep quality in terms of PSQI scoring and glucose control in terms of HbA1c and determine the factors that affect sleep quality among T2DM patients.
Methodology
Research design and setting
Cross-sectional analytic study involving adult individuals with Type 2 diabetes mellitus seen consecutively at various outpatient clinics of the Lung Center of the Philippines and National Kidney and Transplant Institutes from September 2015 to May 2016.
Inclusion criteria
  1. Diagnosed type 2 diabetes patients by physicians at least six months prior using baseline clinical data. Diagnosis according to Philippine Practice Guidelines on the Diagnosis and Management of Diabetes Mellitus:
    • Plasma glucose > 126 mg/dL (7.0 mmol/L) after an overnight fast (Fasting is defined as no caloric intake for at least 8 hours up to a maximum of 14 hours)
    •                  or
    • two-hour plasma glucose > 200 mg/dl (11.1 mmol/l) during an Oral Glucose Tolerance Test. The test should be performed as described by the World Health Organization, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water after an overnight fast of between 8 and 14 hours
    •                  or
    • random plasma glucose > 200 mg/dl (11.1 mmol/l) in a patient with classic symptoms of hyperglycemia (weight loss, polyuria, polyphagia, polydipsia) or with signs and symptoms of hyperglycaemic crisis.
  2. Hba1c within 1 month of the interview to ensure that control will coincide with the PSQI questionnaire which assesses 1 month subjective sleep quality and disturbances
  3. of Filipino descent
  4. aged 18-80, male or female
Exclusion criteria
  1. Type 1 diabetes
  2. diagnosed sleep disorders prior to diagnosis of diabetes
  3. mental illness or use of any kind of psychotropic medication
  4. other endocrine disorders, such as, thyroid disease or chronic use of glucocorticoids, or other drugs that can potentially affect glucose metabolism (antipsychotics, thyroid hormones, etc)
  5. age < 18 years and above 80 years old
  6. Pregnant
  7. end stage renal disease patients on hemodialysis.
Sample Size
The sample size required for this study is 93 patients. This value was computed using the formula introduced by Schohenfield., et al. [18] designed for logistic regression using an odds ratio of 1.32 (where HBA1c > 7% patients has 1.32 times the odds of a poorer subjective sleep quality) based on the reference study [2]. We adjusted the sample size accordingly for a finite population of 150 patients.
E = effect size = 0.367
Zα = 1.960
Zβ = 0.842
Computation
Study Outcomes
Independent variables
Sleep quality will be measured using Pittsburg Sleep Quality Index Questionnaire
Pittsburg Sleep Quality Index Questionnaire (PSQI) is a validated self-completed questionnaire that assesses subjective sleep quality and disturbances over the preceding 1 month. The scale included 19 individual items, which generate seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. The sum of scores for these seven components yields the PSQI global score. PSQI global scores < 5 are defined as ‘‘good sleep quality’’ and scores > 5 are defined as ‘‘poor sleep quality’’. A global PSQI score > 5 has a diagnostic sensitivity  of 89.6% and specificity of 86.5% in differentiating poor from good sleepers. [13]
Presence of Obstructive Sleep Apnea (OSA) will be screened using 2 questionnaires

  1. Presence of excessive daytime sleepiness (which may mean OSA) will be evaluated using the Epworth Sleepiness Scale (ESS) is a validated 8-item questionnaire. ESS scores range from 0 to 24 and higher scores represent greater daytime sleepiness. A score greater than 10 indicates excessive daytime sleepiness and scores were also dichotomized at ≤ 10 or > 10. [14]
  2. Screening for the possibility of OSA will be done using The Berlin questionnaire consists of 10-items relating to snoring, non-restorative sleep, sleepiness while driving, apneas during sleep, hypertension, and body mass index. It categorizes patients to high-risk or low-risk for OSA. [15]
Other variables: Age, sex, status, educational attainment, occupation, number of persons in household and in the bedroom, years since diabetes diagnosis, comorbidities, and medications will also be noted
Dependent variable
The dependent variable in this study is the glycemic control as measured by the HbA1c for the last 3 months. An HbA1c of < 7.0% is considered to be of good control.
Ethical Considerations
Confidentiality and informed consent were the main ethical considerations. This paper underwent full board review approved by the Lung Center of the Philippines Institutional Ethics Review Board. A written informed consent was obtained from all participants.
Study Procedures
Recruitment was done by the PI at the clinic of consenting physicians during designated clinic days. Eligible patients were asked to fill out the PSQI questionnaire, the Epworth Sleepiness Score, and Berlin Questionnaire after giving their informed consent. The researcher was personally available during that time to clarify or answer any questions related to the research. Interview will be done in the clinic’s anteroom to ensure privacy. Medical records were reviewed for all patients to record information on age, sex, height and weight, duration of diabetes, medication usage, comorbidities, laboratory tests, including glycosylated hemoglobin A1c (HbA1c), fasting blood sugar (FBS) and creatinine, if available. HbA1c that will be included for control should be taken within 1 month of the interview to ensure that control will coincide with the PSQI questionnaire which assesses 1 month subjective sleep quality and disturbances
Statistical analysis
Plan of Analysis
Results
360 patients were screened but only 241 were eligible for the study. Forty-six patients have no HbA1c, 5 had type 1 diabetes mellitus, 3 were pregnant, 12 were on dialysis, 18 had endocrine disorders, 3 were over 80 years old and 32 did not give consent. They had an average age of 61.15 + 10.39 years. Majority of the recruited patients were female (60%) and married (72%). Almost half of the patients have been diagnosed with diabetes mellitus for more than 10 years (48%) and have been diagnosed with cardiovascular disease (77%). Table 1 provides their clinical and household characteristics.
  Frequency (%); Mean + SD; Median (Range)
Age (median, s.d.) (years) 61.15 + 10.39
Sex N (%)
Male
Female

98 (40.66)
143 (59.34)
BMI (median, sd) (kg/m2) 25.66 + 4.32
Civil Status N (%)
Single
Married
Widowed
 
21 (8.71)
174 (72.20)
46 (19.09)
Educational Attainment
Below college degree
College and Post graduate
 
60 (24.90)
181 (75.10)
Occupation N (%)
Employed
Unemployed
Self-employed
 
63 (26.14)
134 (55.60)
44 (18.26)
Person in household N (%)
6 or more
Below 6
 
69 (28.63)
172 (71.37)
Person in bedroom 2 (0 to 4)
Currently smoking 18 (7.47)
DM diagnosed more than 10 years 116 (48.13)
Comorbidities
Cardiovascular disease
COPD/asthma
Arthritis
Stroke
DM neuropathy
 
185 (76.76)
19 (7.88)
9 (3.73)
9 (3.73)
4 (1.66)
Medicines
Insulin
Statin
Beta blocker
 
76 (31.54)
82 (34.02)
21 (8.71)
Laboratory examination results
FBS (mg/dl) (n = 209)
HbA1c
 
126.4 (58.5 to 369)
7.64 + 1.98
The quality of sleep of the patients were determined through administering the Pittsburgh Sleep Quality questionnaire. The overall median PSQI score was 6, indicative of poor sleep quality. The highest score obtained was 17, while the lowest was zero.
Table 1: Demographic and clinical characteristics of diabetic adults assesed for sleep quality (N = 241).
 Domains Median (Range)
Sleep duration 1 (0 to 3)
Sleep disturbance 1 (0 to 2)
Sleep latency 1 (0 to 3)
Daytime dysfunction 0 (0 to 3)
Habitual Sleep efficiency 1 (0 to 3)
Overall sleep quality 1 (0 to 3)
Use of sleeping medication 1 (0 to 3)
PSQI Total score 6 (0 to 17)
Table 2: Pittsburgh Sleep Quality Index scores of the study population (n = 241).
The prevalence of poor sleep quality using the three screening tools (Epworth Sleepiness scale and Berlin questionnaire) is summarized in Table 3. Using the PSQI, more than half of the patients were determined to have poor sleep quality (55%). However, only 26% of the patients had increased daytime sleepiness as assessed by the Epworth Sleepiness scale and only 33% of the patients were identified to have a high risk for sleep disordered breathing using the Berlin questionnaire.
  Frequency (%)
Poor sleep quality based on PSQI scoring 133 (55.19)
Excessive daytime sleepiness using Epworth Sleepiness Scale 63 (26.14)
High risk for Sleep disordered breathing using Berlin Questionnaire 79 (32.78)
Table 3: Prevalence of poor sleep quality, excessive daytime sleepiness, and risk for sleep disordered breathing among diabetics (n = 241).
Patients were categorized into either a good glucose control group or a poor glucose control based on their HbA1c (Table 4). Those with good control had median PSQI global score of 5 which was significantly lower than that of the patients with poor control (p 0.00). There were statistical differences between these two groups in terms of five PSQI factors, except for the habitual sleep efficiency and use of sleeping medications. In patients with HbA1c > 7, median sleep latency was significantly longer (30 mins vs. 20 mins p = 0.001) and sleep duration was significantly shorter duration (6 hrs vs. 6.5 hrs; p = 0.018).
  HbA1c > 7
(n = 129)
HbA1c < 7
(n = 111)
P-Value
Median (Range)
Sleep duration 1 (0 to 3) 1 (0 to 3) 0.008
Sleep disturbance 1 (0 to 2) 1 (0 to 2) 0.000
Sleep latency 2 (0 to 3) 1 (0 to 3) 0.001
Daytime dysfunction 1 (0 to 3) 1 (0 to 2) 0.000
Habitual Sleep efficiency 1 (0 to 3) 0 (0 to 3) 0.303
Overall sleep quality 1 (0 to 4) 1 (0 to 3) 0.000
Use of sleeping medication 1 (0 to 3) 0 (0 to 3) 0.069
PSQI Total score 7 (0 to 17) 5 (0 to 16) 0.000
Statistical test used: Mann-Whitney U test
Table 4: Pittsburgh Sleep Quality Index scores of the study population.
The correlation of the quality of sleep of patients to their HbA1c levels was determined. Based on the correlation coefficient, the two variables were determined to be directly, but weakly associated with each other. This relationship was deemed significant (p = 0.000).
Correlation Coefficient Level of Association P-Value
0.2804 Directly Weak Association 0.000
Table 5: Correlation of Sleep quality based on PSQI and HbA1c (n = 241).
We conducted binary logistic regression to determine the predictors of poor sleep quality (Tables 6 and 7). The initial regression model showed that HbA1c is the only predictor of poor sleep quality (p = 0.00). The variables enumerated below account for 15.83% of the variability in the sleep quality among the patients (p = 0.001).
  Poor sleep, PSQI > 6
(n = 133)
Good sleep,
PSQI < 5
(n = 108)
Odds Ratio (95% CI) P-Value
Frequency (%); Mean + SD
Age 60 and up 83 (62.41) 61 (56.48) 1.18 (0.54 to 2.58) 0.686
Female 82 (61.65) 61 (56.48) 1.31 (0.63 to 2.72) 0.472
BMI > 27.5 41 (30.83) 31 (28.70) 1.03 (0.47 to 2.25) 0.950
With companion in bedroom 92 (69.17) 84 (77.78) 0.5 (0.22 to 1.15) 0.102
DM diagnosed more than 10 years 72 (54.14) 44 (40.74) 1.01 (0.97 to 1.06) 0.536
Comorbidities
COPD/Asthma
CVD
DM neuropathy
Arthritis
Stroke
  15 (11.28)
110 (82.71)
3 (2.26)
3 (2.26)
6 (4.51)
  4 (3.70)
75 (69.44)
1 (0.93)
2 (1.85)
3 (2.78)
  3.14 (0.71 to 13.87)
1.26 (0.48 to 3.26)
1.89 (0.12 to 30.04)
1.64 (0.21 to 12.52)
1.41 (0.23 to 8.82)
  0.131
0.639
0.653
0.634
0.712
Medicines
Insulin
Statin
Beta blocker
  48 (36.09)
52 (39.10)
13 (9.77)
  28 (25.93)
30 (27.78)
8 (7.41)
  0.75 (0.34 to 1.65)
1.51 (0.69 to 3.29)
0.79 (0.23 to 2.71)
  0.474
0.300
0.712
Laboratory results
FBS > 126
HbA1c > 7
Creatinine > 1.2
  67 (58.77)
93 (70.45)
11 (10.48)
  39 (41.05)
36 (33.33)
12 (13.19)
  1.41 (0.67 to 2.99)
5.39 (2.45 to 11.85)
0.56 (0.19 to 1.65)
  0.369
0.000
0.295
P-Value = 0.001; R2 = 15.83%
Table 6: Initial model to determine predictors of poor sleep quality among adult diabetic Filipinos based on PSQI scoring.
In the final model, we selected bedroom companion, obstructive lung diseases, and HbA1c (Table 7). Patients who had a companion in the bedroom were less likely to have poor sleep quality (OR 0.4680, 95% CI 0.2431 to 0.9010, p = 0.023). Patients with COPD/Asthma were found to be thrice as likely to have poor sleep quality (OR 3.4508, 95% CI = 1.0144 to 11.7384, p =0.047). Patients with poor glucose control were more likely to have poor sleep quality (OR 5.5012, 95% CI 3.0881 to 9.7997, p = 0.0000. This model account for 13.24% of the variability in the sleep quality among these diabetic patients (p = 0.0000).
  Odds Ratio 95% Confidence Interval P-Value
With companion in bedroom 0.4680 0.2431 to 0.9010 0.023
COPD/asthma 3.4508 1.0144 to 11.7384 0.047
HbA1c > 7 5.5012 3.0881 to 9.7997 0.000
P-Value = 0.0000; R2 = 13.24%
Table 7: Final model to determine predictors of poor sleep quality among adult diabetic Filipinos based on PSQI scoring.
Discussion
Poor sleep quality was noted in 55% of Filipino diabetics in the study population. And among those with poor sleep, 70.45% have poor glycemic control. We found that sleep quality is directly although weakly correlated with glucose control. Among the study population, 33% are high risk for sleep disordered breathing using the Berlin questionnaire and only 26% have excessive daytime sleepiness using ESS. Bedroom companion, asthma/COPD, and HbA1c are predictors of poor sleep quality among adult diabetic Filipinos based on PSQI scoring. Patients who had a companion in the bedroom were less likely to have poor sleep quality (OR 0.4680, p = 0.023). Patients with asthma/COPD and poor glucose control were found to have poor sleep quality (OR 3.4508, 95% CI = 1.0144 to 11.7384, p =0.047) and (OR 5.5012, 95% CI 3.0881 to 9.7997, p = 0.0000) respectively.
These findings are similar with other studies noting significant associations between poor glucose control (HbA1c). Poor sleep quality is present in 33% (De Cunha, 2008 [17] n = 50), 60% (Tang, 2014 [18], n = 551), 71% (Tsai [19], n = 46) and 75% (Bing Qian, 2014 [7] n = 206) among the diabetic population with poor sleep quality using the PSQI questionnaire. Other studies also noted poorer sleep among diabetics in a community based setting using other parameters for sleep quality, with or without HbA1c. [3,5,6, 20-22]
There are many studies noting that insufficient sleep may predispose patients to increased risk for developing impaired fasting glucose and diabetes mellitus. [5, 23-25] Sleep deprivation stimulates increased insulin resistance, catecholamine and cortisol secretion, which could lead to increased plasma glucose. [9,10]
During sleep, initiation of slow-wave sleep (SWS) is temporally associated with transient decreased brain glucose utilization, stimulation of growth hormone release, inhibition of corticotropic activity, decreased sympathetic nervous activity, and increased vagal tone. [26] SWS suppression was investigated in 9 healthy individuals. This resulted in lower insulin sensitivity without compensatory increase in insulin release. An elevation in sympathovagal balance, which could be involved both in the decrease in insulin sensitivity and in the lack of appropriate compensatory increase in insulin in response to glucose. [26] Slow wave sleep was also noted to be significantly decreased amount of SWS in subjects with type 2 diabetes compared to nondiabetic control. [27] Yoda., et al. [23] however noted that among 63 T2DM patients, that among other sleep stages, REM latency alone had a significant and negative correlation with HbA1c (> 9).
A recent systematic review and meta-analysis by Lee., et al. [22] of 10 studies examining sleep quality and glucose control. They noted from the data pooled from 5 studies that there was no difference in the chance of attaining the goal of HbA1c less than 6.5% or 7% (risk ratio: 1.10; 95% CI: 0.85-1.42) in patients with a difficulty in initiating or maintaining sleep. When HbA1c levels were analyzed as a continuous variable, poorer sleep quality was associated with higher HbA1c levels, indicating poor glycemic control (WMD: 0.35%; 95% CI: 0.12-0.58).
In our study, those who have poor glucose control was 5x more likely to have poor sleep quality. This suggests that poor glucose control contributes to poor sleep quality. There was a statistically significant difference in the PSQI domains for sleep duration, sleep disturbance, sleep latency, day dysfunction and sleep quality between the 2 groups. A previous study also noted that a statistically significant difference in PSQI score with regard to glucose control. They also found a statistically significant difference in six of the seven PSQI domains between the 2 groups except the “use of sleeping medications”. [7] We noted the same results where there is a statistically significant difference in sleep latency and sleep duration between the two groups. Poor glucose control are more likely to have poorer sleep quality, longer sleep latency (median 30 mins vs. 20 mins; p=0.001), and shorter duration (median 6 hrs vs. 6.5 hrs; p=0.018) between those with poor and good glucose control. A study noted that a perceived sleep debt of 3 hours per day was associated with an increase in HbA1c level by 1.1% above the median, while in patients with at least 1 complication, a 5-point increase in PSQI score was associated with an increase in HbA1c level by 1.9% above the median. [5]
COPD/asthma was found to be a predictor of poor sleep in our study. This is possibly due to nighttime arousals which could lead to fragmented sleep. COPD patients are found to have diminished amounts of deep sleep and REM sleep. An increased prevalence of insomnia, use of hypnotic medications and an increase in daytime sleepiness compared with the general population was also noted in patients with COPD. Possible mechanisms for frequent arousals in COPD are hypercapnia, increased inspiratory loads and intrinsic PEEP. Sleep deprivation is associated with a mild decrease in forced vital capacity (FVC) (-5%) and forced expiratory volume in 1s (FEV1) (-6%). [28-30] Poor sleep quality is common in patients with COPD, which could lead to worse outcomes.
Our results suggest that the presence of a bedroom companion is protective from poor sleep quality (OR 0.4680, 95% CI 0.2431 to 0.9010, p = 0.023). This finding is also noted in a previous study where they noted better sleep among those married and partnered. [6]
Chasens., et al. [6] noted that those with poor sleep quality and daytime sleepiness were associated with difficulty with multiple aspects of self-care and in reduced adherence to self- management behaviors, which may contribute to poor glucose control.
Sleep disordered breathing is more prevalent among diabetic patients ranging from 58-86% vs. 2-4% among non-diabetics. [6,11] In our study, only 33% are high risk for OSA using the Berlin Questionnaire. We also found that excessive daytime sleepiness occurred in 26% of the patients. This is higher compared to 8.5-20.5% of the patients in other diabetic populations. [8]
Since this is a cross-sectional study, we could not infer that poor sleep quality that "worsens" blood sugar, as well as poor sleep quality as a results of poor sugar control. Additional research is needed to establish whether improving sleep quality will improve glucose control. Other limitations of this study is that patients were not screened for insomnia and depression. Those noted to be high-risk for sleep apnea based on Berlin questionnaire and ESS did not undergo an overnight polysomnogram to confirm presence of sleep disordered breathing, the prevalence may be underestimated.
Conclusion
The prevalence of poor sleep among diabetic Filipinos is high at 55%. Poor sleep quality is directly correlated with poor glucose control. Factors that worsen sleep quality among T2DM are elevated hbA1c, obstructive airway disease and sleeping alone in a bedroom
Conflict of interest
There are no existing conflict of interest.
References
  1. https://www.idf.org/membership/wp/the-philippines. Accessed August 20, 2015
  2. American Diabetes Association. “Diagnosis and classification of diabetes mellitus”. Diabetes Care 33.1 (2010): 62-69.
  3. Luyster FS and Dunbar-Jacob J. “Sleep quality and quality of life in adults with type 2 diabetes”. The Diabetes Educator 37.3 (2011): 347-355.
  4. Song Y., et al. “Disturbed Subjective Sleep in Chinese Females with Type 2 Diabetes on Insulin Therapy.” PLoS ONE 8.1 (2013).  
  5. Knutson KL., et al. “Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus”. Archives of Internal Medicine 166.16 (2006): 1768-1774.
  6. Chasens ER., et al. “Effect of Poor Sleep Quality and Excessive Daytime Sleepiness on Factors Associated with Diabetes Self-Management”. The Diabetes Educator 39.1 (2013): 74-82.
  7. Bing-Qian Z., et al. “Sleep quality and its impact on glycaemic control in patients with type 2 diabetes mellitus”. International Journal of Nursing Sciences 1.3 (2014): 260-265.
  8. Cho E-H., et al. “Sleep Disturbances and Glucoregulation in Patients with Type 2 Diabetes”. Journal of Korean Medical Science 29.3 (2014): 243-247.
  9. Spiegel K., et al. “Impact of Sleep Debt on Metabolic and Endocrine Function”. Lancet 354.1988 (1999): 1435-1439.
  10. Spiegel K., et al. “Effects of poor and short sleep on glucose metabolism and obesity risk”. Nature Reviews Endocrinology 5.5 (2009): 253-261.
  11. Pamidi S and Tasali E. “Obstructive sleep apnea and type 2 diabetes: is there a link?” Fronyiers in Neurology 3 (2012): 1-13.
  12. Karter AJ., et al. “Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE).” Diabetes Care 36.3 (2013): 574-579.
  13. Buysse DJ., et al. “The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice”. Psychiatry Research 28.2 (1989): 193-213.
  14. Johns MW. “A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale”. Sleep 14.6 (1991): 50-55.
  15. Netzer NC., et al. “Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome”. Annals of Internal Medicine 131.7 (1999): 485-491.
  16. Schoenfeld D and Borenstein D. “Calculating the Power or Sample size for the Logistic and Proportional Hazard Models”. Journal of Statistic Computation and Simulation 15.10 (2005): 771-785.
  17. Cunha MC., et al. “Sleep quality in type 2 diabetics”. Revista Latino-Americana De Enfermagem 16.5 (2008): 850-855.
  18. Tang Y., et al. “Interaction of sleep quality and sleep duration on glycemic control in patients with type 2 diabetes mellitus”. Chinese Medical Journal 127.20 (2014): 3543-3547.
  19. Tsai YW., et al. “Impact of subjective sleep quality on glycemic control in type 2 diabetes mellitus”. Family Practice 29.1 (2012): 30-35.
  20. Lamond N., et al. “Factors Predicting Sleep Disruption in Type II Diabetes”. Sleep 23.3 (2000): 415-416.
  21. Fritschi C and Redeker NS. “Contributions of Comorbid Diabetes to Sleep Characteristics, Daytime Symptoms, and Physical Function among Patients with Stable Heart Failure”. Journal of Cardiovascular Nursing 30.5 (2015): 411-419.
  22. Yoda K., et al. “Association between Poor Glycemic Control, Impaired Sleep Quality, and Increased Arterial Thickening in Type 2 Diabetic Patients”. PLOS ONE 10.4 (2015).
  23. Lee SWH., et al. “The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis”. Sleep Medicine Reviews 31 (2016): 91-101.
  24. Lou P., et al. “Relation of sleep quality and sleep duration to type 2 diabetes: a population-based cross-sectional survey”. BMJ Open 2.4 (2012): 000956.
  25. Lou P., et al. “Interaction of sleep quality and sleep duration on impaired fasting glucose: a population-based cross-sectional survey in China”. BMJ Open 4.3 (2014): 004436.
  26. Tasali E., et al. “Slow-wave sleep and the risk of type 2 diabetes in humans”. Proceedings of the National Academy of Sciences of the United States America 105.3 (2008): 1044-1049.
  27. Pallayova M., et al. “Do Differences in Sleep Architecture Exist between Persons with Type 2 Diabetes and Nondiabetic Controls?” Journal of Diabetes Science and Technology 4.2 (2010): 344-352.
  28. McNicholas WT., et al. “Sleep disorders in COPD: the forgotten Dimension”. European Respiratory Review 22.129 (2013): 365-375.
  29. Phillips BA., et al. “The effect of sleep loss on breathing in chronic obstructive pulmonary disease”. Chest 91.1 (1987): 29-32.
  30. Klink M and Quan SF. “Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases”. Chest 91.4 (1987): 540-546.
  31. Jimeno Cecilia. "A Summary of the Philippines UNITE for Diabetes Clinical Practice Guidelines for the Diagnosis and Management of Diabetes (Part I: Screening and Diagnosis of DM).” Journal of the ASEAN Federation of Endocrine Societies 26.1 (2011).
  32. Osonoi Y., et al. “Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitus”. BMC Endocrine Disorders (2015): 15-29.
  33. Plantinga L., et al. “Prevalence of self- reported sleep problems among people with diabetes in the United States”. Preventing Chronic Disease (2012).
  34. Shankar A., et al. “Sleep duration and self-rated health: the National Health Interview Survey 2008”. Sleep 34.9 (2011): 1173-1177.
  35. Peian L., et al. “Effects of sleep duration and sleep quality on prevalence of type 2 diabetes mellitus: A 5-year follow-up study in China”. Diabetes Research and Clinical Practice 109.1 (2015): 178-184.
  36. Kita T., et al. “Short Sleep Duration and Poor Sleep Quality Increases the Risk of Diabetes in Japanese Workers with no Family History of Diabetes”. Diabetes Care 35.2 (2012): 313-318.
Citation: Virginia S Delos Reyes., et al. “Association between Sleep Quality and Glucose Control in Filipino Adults with Type 2 Diabetes Mellitus”. Pulmonary Research and Respiratory Care 1.2 (2017): 102-112.
Copyright: © 2017 Virginia S Delos Reyes., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.